Benchmark analyst Josh Sullivan reiterates Ultralife (NASDAQ:ULBI) with a Buy and maintains $12 price target.
- Headlines
- Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target
Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
16:37
Zoomlion Heavy Industries: Spending HK$12.4071 million to repurchase 2.3 million shares on December 6
Zoomlion Heavy Industry Science and Technology-0.42%
16:35
s.f. holding: hkex has approved the proposed spin-off listing.
S.F. Holding+0.90%
16:33
Iran successfully launched a launch vehicle, sending military satellites and other equipment into the intended orbit.